Home> SOEs>SOEs News

Central SOEs' Emergency Response to Recent COVID-19 Outbreak

Updated: August 06, 2021

The central state-owned enterprises (SOEs) lost no time in supporting the prevention and control in the recent COVID-19 resurgence. 

China National Pharmaceutical Group Co., Ltd. (Sinopharm)'s medical subsidiary in Nanjing, East China's Jiangsu Province, spared no effort to ensure medical testing amid the COVID-19 outbreak in the region.

The company had started providing test equipment and test reagent as early as July 20, collecting samples and giving reagent tests to Nanjing residents.

In the wee hours of July 22, the company immediately set about supplying nucleic acid extraction and detection reagents as soon as it received a message of test kit shortages from a hospital.

So far, the company has provided 284 boxes of reagents and consumables to 15 hospitals in Nanjing, Wuxi, Xuzhou, Yancheng and Nantong, and delivered 1,430 boxes to other testing assistance points in Jiangsu.


Medical workers at Sinopharm's medical subsidiary in Nanjing, prepare nucleic acid extraction and detection reagents for testing. [Photo/sasac.gov.cn]

The logistic department of Sinopharm's Jiangsu branch took on the emergency mission to transport anti-pandemic drugs to the public health medical center in Tangshan, Jiangning district at 2:30 pm on July 23.

The employees delivered the drugs to the anti-pandemic frontline within eight hours despite Typhoon In-Fa.

Sinopharm's Nanjing subsidiary also shouldered the anti-pandemic transport mission in Jianye district, sending more than 35,000 supply items since July 20.


Two medical workers rush to carry the nucleic acid reagents to the hospital. [Photo/sasac.gov.cn]

Medical institutes affiliated to China General Technology (Group) Holding Co Ltd (Genertec) also joined in the anti-pandemic frontline.

From noon of August 1, a Henan-based subsidiary of Genertec's Health China dispatched about 40,000 employees to collect nucleic acid samples from local residents and on Aug 3, the company sent medical workers to other areas after completion of the first round of nucleic testing in Zhengzhou, capital city of Henan Province.

Other subsidiaries of Health China in Beijing, Shanghai and Sichuan Province were also taking on pandemic prevention and control missions following the instruction of local governments.


Medical workers of Genertec's Health China collect nucleic samples from residents. [Photo/sasac.gov.cn]

Hospitals affiliated to China Resources (Holdings) Co., Ltd. (CR) sent medical volunteer groups to Nanjing to support nucleic sample collection on July 22.

So far, CR's hospital in Shenyang, Northeast China's Liaoning Province, has sent 450 medical workers and collected 25,000 nucleic samples.

Its medical institutes also highly valued medical workers' protection and closed-loop management of patients while strengthening anti-pandemic training to raise awareness of other workers at the hospitals.

(Executive editor: Niu Yilin)